Hyaline-vascular castleman disease: A rare cause of solitary subcutaneous soft tissue mass

American Journal of Dermatopathology

Volumn 32, Issue 3, 2010, Pages 293-297

  Naghashpour, Mojdeh ^a   Cualing, Hernani D ^a   Szabunio, Margaret ^a   Bui, Marilyn M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Castleman disease; Hyaline vascular type; Subcutaneous; Superficial soft tissue

Indexed keywords

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; HYALINE VASCULAR CASTLEMAN DISEASE; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SOFT TISSUE TUMOR;

DIAGNOSIS, DIFFERENTIAL; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; HYALIN; LYMPH NODES; LYMPHOMA; MIDDLE AGED; PSEUDOLYMPHOMA; RADIOGRAPHY, THORACIC; SKIN NEOPLASMS; SUBCUTANEOUS TISSUE; THORAX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77951735236     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181b7269a     Document Type: Article

References (37)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956;9:822-830.
2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-683.
3. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol. 1988;5:346-364.
4. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol. 1993;20:636-647.
5. Frizzera G, Banks PM, Massarelli G, et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients. Am J Surg Pathol. 1983;7:211-231.
6. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496-2506.
7. Liu W, Lacouture ME, Jiang J, et al. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. J Cutan Pathol. 2006;33(Suppl 2):46-51.
8. Frizzera G, Peterson BA, Bayrd ED, et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985;3:1202-1216.
9. Chan JK, Tsang WY, Ng CS. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease. Am J Surg Pathol. 1994;18:517-525.
10. GeraldW, Kostianovsky M, Rosai J. Development of vascular neoplasia in Castleman's disease. Report of seven cases. Am J Surg Pathol. 1990;14: 603-614.
11. Erdogan A, Eser I, Ozbilim G. Posterior mediastinal localization of Castleman's disease: report of a case. Surg Today. 2004;34:772-773.
12. Kurai M, Kondo R, Kobayashi N, et al. Castleman's disease arising from the chest wall. Jpn J Thorac Cardiovasc Surg. 2006;54:555-557.
13. Hummel P, Benjamin V, Zagzag D. March 2002: 28-year-old woman with neck and back pain. Brain Pathol. 2002;12:395-397.
14. Kim JH, Jun TG, Sung SW, et al. Giant lymph node hyperplasia (Castleman's disease) in the chest. Ann Thorac Surg. 1995;59:1162-1165.
15. Johnson WK, Ros PR, Powers C, et al. Castleman disease mimicking an aggressive retroperitoneal neoplasm. Abdom Imaging. 1994;19:342-344.
16. Williams HR, Millner PA, Coral A. Castleman's disease of the erector spinae muscle. Skeletal Radiol. 1998;27:637-640.
17. Skelton HG, Smith KJ. Extranodal multicentric Castleman's disease with cutaneous involvement. Mod Pathol. 1998;11:93-98.
18. Sleater J, Mullins D. Subcutaneous Castleman's disease of the wrist. Am J Dermatopathol. 1995;17:174-178.
19. Kazakov DV, Fanburg-Smith JC, Suster S, et al. Castleman disease of the subcutis and underlying skeletal muscle: report of 6 cases. Am J Surg Pathol. 2004;28:569-577.
20. Moon WK, Im JG, Kim JS, et al. Mediastinal Castleman disease: CT findings. J Comput Assist Tomogr. 1994;18:43-46.
21. Nguyen DT, Diamond LW, Hansmann ML, et al. Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology. 1994;24:437-443.
22. Menke DM, Tiemann M, Camoriano JK, et al. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol. 1996;105:268-276.
23. Amin HM, Medeiros LJ, Manning JT, et al. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease. Am J Surg Pathol. 2003;27:91-100.
24. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989;74: 1360-1367.
25. Mori Y, Nishimoto N, Ohno M, et al. Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J Med Virol. 2000;61:332-335.
26. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 1999;93:4034-4043.
27. Larroche C, Cacoub P, Soulier J, et al. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol. 2002;69:119-126.
28. Ruco LP, Gearing AJ, Pigott R, et al. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells. Histopathology. 1991;19:523-528.
29. Chan AC, Chan KW, Chan JK. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology. 2001;38: 510-518.
30. Kazakov DV, Morrisson C, Plaza JA, et al. Sarcoma arising in hyalinevascular Castleman disease of skin and subcutis. Am J Dermatopathol. 2005;27:327-332.
31. Sze DY, Shelton AA. SIR 2008 annual meeting film panel case: Castleman disease complicated by follicular dendritic cell sarcoma. J Vasc Interv Radiol. 2008;19:1141-1144.
32. Pauwels P, Dal Cin P, Vlasveld LT, et al. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells. Am J Surg Pathol. 2000;24:882-888.
33. Cokelaere K, Debiec-Rychter M, De Wolf-Peeters C, et al. Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis. Am J Surg Pathol. 2002;26:662-669.
34. Hsu SM, Waldron JA, Xie SS, et al. Expression of interleukin-6 in Castleman's disease. Hum Pathol. 1993;24:833-839.
35. Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001;92:670-676.
36. Kang N, Chung JW, Jung SN. Rare location of Castleman disease in the temporal region. J Craniofac Surg. 2009;20:830-832.
37. Bergman R, Khamaysi Z, Sahar D, et al. Cutaneous lymphoid hyperplasia presenting as a solitary facial nodule: clinical, histopathological, immunophenotypical, and molecular studies. Arch Dermatol. 2006;142: 1561-1566.